Connecticut § 20-611 (Formerly Sec. 20-175b). Advertising legend drug prices.

Connecticut Statutes

§ 20-611 — (Formerly Sec. 20-175b). Advertising legend drug prices.

Connecticut § 20-611

Title 20Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards

Ch. 400jPharmacy

This text of Connecticut § 20-611 ((Formerly Sec. 20-175b). Advertising legend drug prices.) is published on Counsel Stack Legal Research, covering Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Conn. Gen. Stat. § 20-611 (2026).

Text

A pharmacist or any person holding a pharmacy license (1) may advertise the price of any legend drug sold at retail based on the prescription of a prescribing practitioner, provided, each such advertisement shall clearly state the period during which the advertised price or prices shall remain in effect and shall not contain any statement indicating that the advertised price or prices are subject to change without notice; and (2) shall disclose, upon request, the price of any such legend drug to any prospective purchaser. See chapter 418 re Uniform Food, Drug and Cosmetic Act. See chapter 419 re retail drug control.

Free access — add to your briefcase to read the full text and ask questions with AI

A pharmacist or any person holding a pharmacy license (1) may advertise the price of any legend drug sold at retail based on the prescription of a prescribing practitioner, provided, each such advertisement shall clearly state the period during which the advertised price or prices shall remain in effect and shall not contain any statement indicating that the advertised price or prices are subject to change without notice; and (2) shall disclose, upon request, the price of any such legend drug to any prospective purchaser. See chapter 418 re Uniform Food, Drug and Cosmetic Act. See chapter 419 re retail drug control.

Legislative History

(P.A. 75-95, S. 1, 3; P.A. 95-264, S. 33.) History: P.A. 95-264 made technical changes and changed references to “drug, medicine or chemical” to “legend drug”; Sec. 20-175b transferred to Sec. 20-611 in 1997.